Obese (ob) gene expression in abdominal subcutaneous adipocytes from lean and obese humans was examined. The full coding region of the ob gene was isolated from a human adipocyte cDNA library. Translation of the insert confirmed the reported amino acid sequence. There was no difference in the sequence of an reverse transcription PCR product of the coding region from five lean and five obese subjects. The nonsense mutation in the ob mouse which results in the conversion of arginine 105 to a stop codon was not present in human obesity. In all 10 human cDNAs, arginine 105 was encoded by CGG, consequently two nucleotide substitutions would be required to result in a stop codon. To compare the amount of ob gene expression in lean and obese individuals, radiolabed primer was used in the PCR reaction with (Iactin as a control. There was 72% more ob gene expression (P < 0.01) in eight obese subjects (body mass index, BMI = 42.8±2.7) compared to eight lean controls (BMI = 22.4±0.8). Regression analysis indicated a positive correlation between BMI and the amount of ob message (P < 0.005). There was no difference in the amount of ,B-actin expression in the two groups. These results provide evidence that ob gene expression is increased in human obesity; furthermore, the mutations present in the mouse ob gene were not detected in the human mRNA population. (J. Clin. Invest. 1995. 95:2986-2988
Introduction
The genetic and/or environmental influences that contribute to the development of human obesity are poorly understood ( 1 -5). Friedman and coworkers have recently cloned the obese (ob)' gene in mice and also found its human homologue (6) .
These investigators postulate that the product of the ob gene, which is expressed exclusively in the adipocyte, is a satiety factor that controls food intake by signaling the hypothalamus when the store of energy is sufficient. Previous studies (transfusion and parabiosis) have predicted the existance of such a circulating factor (reviewed in references 7, 8) . In the ob/ob mouse, two separate mutations in the ob gene result in either a premature stop codon or the total absence of ob mRNA. Without this signaling protein, the mouse overeats resulting in the obese phenotype.
The present study provides evidence that the mutations present in the mouse ob gene are not present in obese humans.
Methods
Subjects. Eight healthy lean (five female/three male, body mass index (BMI) 22 (9) . None of the individuals were taking medications or had any evidence of metabolic disease other than obesity. All biopsies were performed in the morning after an overnight fast. Tissue was transported to the laboratory in saline and immediately digested by collagenase.
This protocol has been approved by the Institutional Review Board at Thomas Jefferson University, Philadelphia, PA.
Reverse transcription PCR (RT-PCR). Adipocytes were isolated by collagenase digestion of outpatient subcutaneous adipose tissue biopsies as previously described (9) . Total RNA was obtained by guanidinium thiocyanate-phenol-chloroform extraction (10) . First strand cDNA was synthesized from 1 Mg of total RNA using random hexamers as described in the GeneAmp RNA PCR kit (Perkin-Elmer Corp., Branchburg, NJ). As only the predicted amino acid sequence was available for the human ob gene product (6) the following degenerate primers were synthesized: To determine the amount of ob gene expression in lean and obese individuals, first strand cDNA was generated as described above. The reaction was then split equally into two separate tubes for the PCR reaction. The first tube was used to amplify -350 base pairs of the ob Figure 1 . Sequence of the entire coding region of the human ob gene. The sequence was obtained from a human adipocyte cDNA library and codes for 167 amino acids (numbering based on that in reference 6). The primer sequences used for the analysis in Fig. 3 (Fig. 1) . The translated sequence codes for a protein of 167 amino acids which are identical to those previously reported for humans (6) .
The ob gene mRNA from five lean and five obese individuals was sequenced for possible mutations as observed in the ob/ob mouse. The sequence derived from the lean and obese cDNA were identical. It is important to note that, in contrast to the mouse codon for arginine 105 (CGA), human arginine 105 is encoded by CGG. It is, therefore, much less likely that the human codon could mutate to a stop codon. The cDNA derived from all 10 subjects studied contained the complete codon for glutamine 49.
Specificity ofob gene expression. Using primers that enclose amino acids 2-118, several human tissues were examined for the expression of the ob gene. As shown in Fig. 2 , ob gene expression was limited in humans to the adipocyte. ,B-actin mRNA, run as a positive control through the RT-PCR reaction, was expressed in all tissues studied.
Expression of ob gene in lean and obese individuals. Ob gene expression in lean versus obese individuals was examined by measuring the incorporation of radiolabeled downstream primer into the 350-bp PCR product. As a control, a radiolabeled 220-bp fragment of the mRNA for,/-actin was generated from the same reverse transcription reaction for each individual. There was no difference in the amount of ,6-actin mRNA between the lean and obese groups. However, as shown in Fig.  3 , there was a positive correlation between ob gene expression and the BMI of the individual studied. Linear regression analysis indicated that the correlation was highly significant (P < 0.005). Overall, there was 72% more ob gene expression in the obese subjects (13.1±1.0 relative units; n = 8) compared to the lean (7.6±1.0 relative units; n = 8) when normalized to the amount of message for f3-actin (P < 0.01; one-way ANOVA).
Discussion
The amino acid sequence of the human homologue to the mouse ob gene product has recently been published (6) . codon. It should be noted that although the two characterized defects in the mouse mRNA were not detected in the 10 human subjects studied, this does not rule out the possibility that these or other deleterious mutations could occur in a subpopulation of obese individuals. Using RT-PCR we have demonstrated that there is significantly more ob gene expression in the subcutaneous adipose tissue of obese individuals when compared to lean subjects. Assuming that the ob gene product does indeed code for a satiety factor, this observation suggests that the adipocyte is functioning normally and that the defect in human obesity lies elsewhere. One possibility is that the receptor for the ob protein is blocked or defective. A second possibility is that the protein is degraded and never reaches its target. A third possibility is that the ob gene product signals for the release of another, as yet unidentified hormone which is defective. Each of these possibilities is predicated on the assumption that the ob gene actually codes for a satiety factor and not some other protein.
Positive proof of this awaits the isolation of the protein in the blood and the demonstration that it does indeed influence appetite.
In summary, ob gene expression in humans, as in mice, appears to be limited to the adipocyte. However, unlike the mouse model, no lack of message or flawed message was detected in the human subjects. Additionally, ob gene expression was highly correlated with BMI. Further work is necessary to elucidate the exact role of the ob gene in human obesity.
